Results 1 to 10 of about 6,312,461 (358)

A shared latent space matrix factorisation method for recommending new trial evidence for systematic review updates

, 2018
Clinical trial registries can be used to monitor the production of trial evidence and signal when systematic reviews become out of date. However, this use has been limited to date due to the extensive manual review required to search for and screen ...
Bashir, Rabia, Bourgeois, Florence T., Coiera, Enrico, Dunn, Adam G., Orenstein, Liat, Surian, Didi   +5 more
core   +1 more source

Chapter Three. EED library as a basis for systematic reviews [PDF]

, 2016
3.1 Defining Systematic Review Question Priorities 3.2 Determining Relevance to the Systematic Review 3.3 Acquisition of References and Copyright Fair Use Compliance 3.4 Documenting Relevance to the Systematic Review 3.5 Data Extraction for the ...
Denno, Donna M, Musser, Christine A, Nelson, Zakia C, Tarr, Phillip I, VanBuskirk, Kelley M   +4 more
core   +1 more source

Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis

Cancer Biology & Medicine, 2022
Objective: This study aimed to assess the efficacy and safety of various neoadjuvant regimens for patients diagnosed with early-stage or locally advanced triple-negative breast cancer (TNBC). Methods: Medline, EMBASE, Cochrane Library, and Web of Science
Junjie Li, Li Chen, Wei Tan, Fang Qi, Yang Zhang, Zhonghua Wang, Zhimin Shao   +6 more
doaj   +1 more source

Gestational diabetes mellitus in relation to serum per- and polyfluoroalkyl substances: A scoping review to evaluate the need for a new systematic review [version 2; peer review: 2 approved]

F1000Research
Background Per- and polyfluoroalkyl substances (PFAS) were used or are being used in the manufacturing of products, including consumer-use products. The resulting environmental contamination has led to widespread human exposure.
Sebastian Hoffmann, Matthew P. Longnecker, Ghazaleh Aali, Anna K. Porter, Farhad Shokraneh   +4 more
doaj   +1 more source

How reliable are systematic reviews in empirical software engineering? [PDF]

, 2010
BACKGROUND – the systematic review is becoming a more commonly employed research instrument in empirical software engineering. Before undue reliance is placed on the outcomes of such reviews it would seem useful to consider the robustness of the ...
Kitchenham, BA, MacDonell, SG, Mendes, E, Shepperd, MJ   +3 more
core   +2 more sources

Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema

Systematic Reviews, 2023
Background Different network meta-analyses (NMAs) on the same topic result in differences in findings. In this review, we investigated NMAs comparing aflibercept with ranibizumab for diabetic macular oedema (DME) in the hope of illuminating why the ...
Jing Wu, Clive Adams, Xiaoning He, Fang Qi, Jun Xia   +4 more
doaj   +1 more source

Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis

Frontiers in Pharmacology, 2022
Background: Antiangiogenic therapy with anti-vascular endothelial growth factor (VEGF) is commonly used to treat diabetic macular edema (DME), which can reduce edema, improve vision, and prevent further visual loss.
Xian Wang, Xiaoning He, Fang Qi, Jia Liu, Jing Wu   +4 more
doaj   +1 more source

Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis

Reproductive Medicine and Biology
Background Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown.
Shinnosuke Komiya, Jun Watanabe, Takero Terayama, Kyosuke Kamijo, Hidetaka Okada   +4 more
doaj   +1 more source

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

The Journal of Clinical Hypertension, 2021
Since the COVID‐19 pandemic, physicians concerned about the potential adverse effects of angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs).
Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng, Deping Liu   +9 more
doaj   +1 more source

Gout [PDF]

, 2008
INTRODUCTION: Gout affects about 5% of men and 1% of women, with up to 80% of people experiencing a recurrent attack within 3 years. METHODS AND OUTCOMES:We conducted a systematic review and aimed to answer the following clinical questions: What are the
Underwood, Martin
core   +3 more sources